Anti-coagulant aptamers.
暂无分享,去创建一个
[1] Mark F. Kubik,et al. High-affinity RNA ligands to human alpha-thrombin , 1994, Nucleic Acids Res..
[2] B. Sullenger,et al. RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.
[3] Subash C B Gopinath,et al. A potent anti-coagulant RNA aptamer inhibits blood coagulation by specifically blocking the extrinsic clotting pathway , 2006, Thrombosis and Haemostasis.
[4] Steven A Soper,et al. Designing highly specific biosensing surfaces using aptamer monolayers on gold. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[5] Brian K Adler,et al. Unfractionated Heparin and Other Antithrombin Mediated Anticoagulants , 2004, American Society for Clinical Laboratory Science.
[6] A. Heckel,et al. Light regulation of aptamer activity: an anti-thrombin aptamer with caged thymidine nucleobases. , 2005, Journal of the American Chemical Society.
[7] Koji Sode,et al. Novel electrochemical sensor system for protein using the aptamers in sandwich manner. , 2005, Biosensors & bioelectronics.
[8] M. Bowser,et al. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. , 2004, Analytical chemistry.
[9] A. Tulinsky,et al. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. , 1994, The Journal of biological chemistry.
[10] A. Schmidt,et al. Structure-function relationships in factor IX and factor IXa. , 2003, Trends in cardiovascular medicine.
[11] F. Church,et al. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin , 2000, FEBS letters.
[12] J. Latham,et al. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. , 1994, Nucleic acids research.
[13] P. Urvil,et al. Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function , 1998 .
[14] Y. Komatsu,et al. New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX , 2005, Nucleic acids research.
[15] A. Pardi,et al. High-resolution molecular discrimination by RNA. , 1994, Science.
[16] George Quick,et al. Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.
[17] L. C. Bock,et al. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. , 1993, Blood.
[18] C. Giancola,et al. A new modified thrombin binding aptamer containing a 5′–5′ inversion of polarity site , 2006, Nucleic acids research.
[19] B. Shen,et al. Screening of functional antidotes of RNA aptamers against bovine thrombin , 2004, FEBS letters.
[20] D. Monroe,et al. Platelets and thrombin generation. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[21] Penmetcha K. R. Kumar,et al. Aptamer-derived nucleic acid oligos: applications to develop nucleic acid chips to analyze proteins and small ligands. , 2005, Analytical chemistry.
[22] S. Gopinath,et al. Snake-venom-derived Factor IX-binding protein specifically blocks the gamma-carboxyglutamic acid-rich-domain-mediated membrane binding of human Factors IX and X. , 2007, The Biochemical journal.
[23] Itamar Willner,et al. Nucleic acid-functionalized Pt nanoparticles: Catalytic labels for the amplified electrochemical detection of biomolecules. , 2006, Analytical chemistry.
[24] S. Gopinath. Methods developed for SELEX , 2006, Analytical and bioanalytical chemistry.
[25] M. Mascini,et al. Analytical applications of aptamers. , 2005, Biosensors & bioelectronics.
[26] B. Sullenger,et al. Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.
[27] E. Vermaas,et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.
[28] Andrew D Ellington,et al. Aptamer:toxin conjugates that specifically target prostate tumor cells. , 2006, Cancer research.
[29] G. Mayer,et al. A new anticoagulant-antidote pair: control of thrombin activity by aptamers and porphyrins. , 2007, Journal of the American Chemical Society.
[30] B. Sullenger,et al. Nucleic acid aptamers in therapeutic anticoagulation , 2005, Thrombosis and Haemostasis.
[31] Jean-Luc Pellequer,et al. Model of a Ternary Complex between Activated Factor VII, Tissue Factor and Factor IX , 2002, Thrombosis and Haemostasis.
[32] M F Kubik,et al. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. , 1997, Journal of molecular biology.
[33] Subash C B Gopinath,et al. An RNA aptamer that discriminates bovine factor IX from human factor IX. , 2006, Journal of biochemistry.
[34] Andrew D Ellington,et al. Aptamer therapeutics advance. , 2006, Current opinion in chemical biology.
[35] M. Famulok,et al. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors. , 2005, Biosensors & bioelectronics.
[36] Kevin W Plaxco,et al. Aptamer-based electrochemical detection of picomolar platelet-derived growth factor directly in blood serum. , 2007, Analytical chemistry.
[37] Wei-xing Li,et al. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation , 1994 .
[38] An anticoagulant with light-triggered antidote activity. , 2006, Angewandte Chemie.
[39] S. Steinhubl,et al. First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity , 2006, Circulation.
[40] B. Shen,et al. RNA aptamers specific for bovine thrombin , 2003, Journal of molecular recognition : JMR.
[41] B. Sullenger,et al. Blocking the Initiation of Coagulation by RNA Aptamers to Factor VIIa , 2000, Thrombosis and Haemostasis.